Bone Mineral Density in Patients with Atopic Dermatitis on Chronic  Topical/Oral Corticosteroids

Dr. Kiran Chahal, Dr. Udit, Dr. Dhananjay Malage, Mr. Vishal Pol

Bone Mineral Density in Patients with Atopic Dermatitis on Chronic Topical/Oral Corticosteroids

Authors

Dr. Kiran Chahal, Dr. Udit, Dr. Dhananjay Malage, Mr. Vishal Pol

Keywords:

Atopic dermatitis, corticosteroids, bone mineral density, osteoporosis, DEXA, glucocorticoids

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disorder frequently managed withcorticosteroids. Long-term systemic corticosteroid therapy is associated with reduced bonemineral density (BMD), while the effects of chronic topical corticosteroids on bone health are less clearly defined

References

Williams H, Stewart A, von Mutius E. Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008; 121:947-54.e15.

Odhiambo JA, Williams HC, Clayton TO. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009; 124:1251-8.e23.

Downloads

Published

2025-10-17

How to Cite

Dr. Kiran Chahal, Dr. Udit, Dr. Dhananjay Malage, Mr. Vishal Pol. (2025). Bone Mineral Density in Patients with Atopic Dermatitis on Chronic Topical/Oral Corticosteroids. International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 2530–2537. Retrieved from https://www.ijprt.org/index.php/pub/article/view/1084